← FDA Drug Approvals (Drugs@FDA)
KEVZARA
BLA · Biologics License Application · Sponsor: SANOFI SYNTHELABO · Approved 2017-05-22
Drug application
- FDA Application #
BLA761037- Application type
- Biologics License Application
- Brand name
- KEVZARA
- Generic name
- SARILUMAB
- Active ingredients
- SARILUMAB
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- SANOFI SYNTHELABO
- Manufacturer
- Sanofi-Aventis U.S. LLC
- First approval
- 2017-05-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown